Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channel subfamily Q member 3 (KCNQ3) is a voltage-gated potassium channel subunit that plays a crucial role in regulating neuronal excitability. It forms part of the M-channel, which is responsible for the M-current, a potassium current that helps stabilize the membrane potential and prevent excessive neuronal firing. Mutations in KCNQ3 are associated with benign familial neonatal seizures.
Retigabine activates KCNQ3 channels, increasing potassium ion conductance and hyperpolarizing the cell membrane, thus reducing neuronal excitability.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium Channel Subfamily Q Member 3 (KCNQ3).